Kevin Thornal is the Group President, Global Businesses and the Americas at Zimmer Biomet Holdings, Inc., a leading global medical technology company focused on musculoskeletal health solutions. With more than 25 years of experience in the orthopedics and medical device industry, Thornal joined Biomet (now Zimmer Biomet) in 1995 as Director of Marketing for the company's spine business. He quickly advanced through key leadership roles, including Vice President of Marketing and President of the Global Spine business, where he spearheaded the development and launch of innovative spinal implant systems and biologics that expanded market share and drove double-digit revenue growth. Under Thornal's stewardship, Zimmer Biomet's spine division became a market leader, marked by strategic acquisitions, such as the integration of Breaking Boundaries and advanced enabling technologies like the ROSA Robotic System. His expertise in commercial strategy and global operations has been pivotal in navigating complex regulatory landscapes and fostering cross-functional teams to deliver patient-centric innovations in areas including bone growth stimulation and minimally invasive procedures. In his current role, Thornal oversees a broad portfolio encompassing the Americas region as well as global businesses in sports medicine, extremities, trauma, robotics, and surgical technologies. He plays a critical role in executing Zimmer Biomet's growth strategy, including key partnerships and product launches that enhance surgical precision and outcomes, positioning the company for sustained leadership in transforming orthopedic care worldwide.